Pre-quit depression level and smoking expectancies for mood management predict the nature of smoking withdrawal symptoms in college women smokers

Addictive Behaviors

Volumn 34, Issue 5, 2009, Pages 481-483

  Copeland, Amy L ^a   Kulesza, Magdalena ^a   Hecht, Gerald S ^b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b SOUTHERN UNIVERSITY   (United States)

Author keywords

Depression and smoking; Gender and smoking; Smoking expectancies; Smoking withdrawal

Indexed keywords

ADULT; DEPRESSION; FEMALE; HUMANS; MOOD DISORDERS; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; YOUNG ADULT;

EID: 60649119814     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2008.12.007     Document Type: Article

References (20)

1. Beck A.T., Steer R.A., and Brown G.K. Manual for the Beck Depression Inventory-II (1996), Psychological Corporation, San Antonio, TX
2. Borelli B., Bock B., King T., Pinto B., and Marcus B.H. The impact of depression on smoking cessation in women. American Journal of Preventive Medicine 12 (1996) 378-387
3. Brandon T.H. Negative affect as motivation to smoke. Current Directions in Psychological Science 3 (1994) 33-37
4. Brandon T.H., and Baker T.B. The smoking consequences questionnaire: The subjective expected utility of smoking in college students. Psychological Assessment 3 (1991) 484-491
5. Breslau N., Kilbey M.M., and Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: Findings from an epidemiological study of young adults. American Journal of Psychiatry 149 (1992) 464-469
6. Copeland A.L., Brandon T.H., and Quinn E.P. The Smoking Consequences Questionnaire-Adult: Measurement of smoking outcome expectancies of experienced smokers. Psychological Assessment 7 (1995) 484-494
7. DiClemente C.C., Prochaska J.O., Fairhurst S.K., Velicer W.F., Velasquez M.M., and Rossi J.S. The process of smoking cessation: An analysis of precontemplation, contemplation, and preparation stages of change. Journal of Consulting and Clinical Psychology 59 (1991) 295-304
8. Heatherton T.F., Kozlowski L.T., Frecker R.C., and Fagerström K.O. The Fagerström test for nicotine dependence: A revision of the Fagerström tolerance questionnaire. British Journal of Addiction 86 (1991) 1119-1127
9. Hughes J.R. Effects of abstinence from tobacco: Valid symptoms and time course. Nicotine & Tobacco Research 9 (2007) 315-327
10. Japuntich S.J., Smith S.S., Jorenby D.E., Piper M.E., Fiore M.C., and Baker T.B. Depression predicts smoking early but not late in a quit attempt. Nicotine & Tobacco Research 9 (2007) 677-686
11. Krishnan K.R. MAOIs. In: Schatzberg A.F., and Nemeroff C.B. (Eds). Textbook of psychopharmacology. 3rd ed. (2004), American Psychological Association Press, Washington D.C. 303-314
12. Leventhal A.M., Waters A.J., Boyd S., Moolchan E.T., Lerman C., and Pickworth W.B. Gender differences in acute tobacco withdrawal: Effects on subjective, cognitive, and physiological measures. Experimental & Clinical Psychopharmacology 15 (2007) 21-36
13. McNair M., Lorr A., and Droppleman L.F. Manual for the Profile of Mood States (1971), Educational and Industrial Testing Service, San Diego
14. Patten C.A., and Martin J.E. Measuring tobacco withdrawal: A review of self-report questionnaires. Journal of Substance Abuse 8 (1996) 93-113
15. Perkins K.A. Smoking cessation in women: Special considerations. CNS Drugs 15 (2001) 391-411
16. Prochaska J.J., Hall S.M., Tsoh J.Y., Eisendrath S., Rossi J.S., Redding C.A., et al. Treating tobacco dependence in clinically depressed smokers: Effect of smoking cessation on mental health functioning. American Journal of Public Health 98 3 (2008) 446-448
17. Shiffman S.M., and Jarvik M.E. Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology 50 (1976) 35-39
18. Villegier A.S., Lotfipour S., McQuown S.C., Belluzzi J.D., and Leslie F.M. Tranylcypromine enhancement of nicotine self-administration. Neuropsychopharmacology 52 (2007) 1415-1425
19. Villegier A.S., Salomon L., Granon S., Changeux J.P., Belluzzi J.D., Leslie F.M., et al. MAOIs allow locomotor and rewarding responses to nicotine. Neuropsychopharmacology 31 (2006) 1704-1713
20. Wooters T.E., and Bardo M.T. The MAOI phenelzine enhances the discriminative stimulus effects of nicotine in rats. Behavioral Pharmacology 18 (2007) 601-608